Interferon β-1b Therapy in Chronic Viral Dilated Cardiomyopathy-Is There a Role for Specific Therapy?

Journal of Cardiac Failure

Volumn 16, Issue 4, 2010, Pages 348-356

  Zimmermann, Oliver ^a   Rodewald, Christoph ^a   Radermacher, Michael ^a   Vetter, Martin ^a   Wiehe, Juliane M ^a   Bienek Ziolkowski, Magdalena ^a   Hombach, Vinzenz ^a   Torzewski, Jan ^b  

^a UNIVERSITY OF ULM   (Germany)

^b Klinik Immenstadt   (Germany)

Author keywords

biopsy; heart failure; interferon 1b; outcome; Virus

Indexed keywords

INTERFERON BETA SERINE;

ADULT; AGED; ANOREXIA; ARTHRALGIA; ARTICLE; BALANCE IMPAIRMENT; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG FEVER; DRUG INDUCED HEADACHE; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; FATIGUE; FEMALE; HAIR LOSS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HUMAN; INJECTION SITE REACTION; MALE; MYALGIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SHIVERING; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT; VIRUS GENOME; VIRUS INFECTION; VOMITING;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GENOME, VIRAL; HUMANS; INTERFERON-BETA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; VIRUS DISEASES; YOUNG ADULT;

EID: 77950297192     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.12.016     Document Type: Article

References (39)

1. Dec G.W., and Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 331 (1994) 1564-1575
2. Coughlin S.S., Neaton J.D., Sengupta A., and Kuller L.H. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 139 (1994) 166-172
3. Stewart S., Jenkins A., Buchan S., McGuire A., Capewell S., and McMurray J.J. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Failure 4 (2002) 361-371
4. Saß H., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation 112 (2005) 1825-1852
5. Cooper L.T., Baughman K.L., Feldman A.M., Frustaci A., Jessup M., Kuhl U., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116 (2007) 2216-2233
6. Kuhl U., Noutsias M., Seeberg B., and Schultheiss H.P. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75 (1996) 295-300
7. Dennert R., Crijns H.J., and Heymans S. Acute viral myocarditis. Eur Heart J 29 (2008) 2073-2082
8. Hershberger R.E., Lindenfeld J., Mestroni L., Seidman C.E., Taylor M.R., and Towbin J.A. Heart Failure Society of America. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J Card Fail 15 (2009) 83-97
9. Lappé J.M., Pelfrey C.M., and Tang W.H. Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail 14 (2008) 521-530
10. Mason J.W., O'Connell J.B., Herskowitz A., Rose N.R., McManus B.M., Billingham M.E., et al. A clinical trial of immuno-suppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333 (1995) 269-275
11. Parrillo J.E., Cunnion R.E., Epstein S.E., Parker M.M., Suffredini A.F., Brenner M., et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321 (1989) 1061-1068
12. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., Glanowska G., Wilczewski P., Niklewski T., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104 (2001) 39-45
13. Aretz H.T. Myocarditis: the Dallas criteria. Hum Pathol 18 (1987) 619-624
14. Pauschinger M., Bowles N.E., Fuentes-Garcia F.J., Pham V., Kühl U., Schwimmbeck P.L., et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99 (1999) 1348-1354
15. Fujioka S., Kitaura Y., Ukimura A., Deguchi H., Kawamura K., Isomura T., et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36 (2000) 1920-1926
16. Why H.J., Meany B.T., Richardson P.J., Olsen E.G., Bowles N.E., Cunningham L., et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89 (1994) 2582-2589
17. Kühl U., Pauschinger M., Seeberg B., Lassner D., Noutsias M., Poller W., et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112 (2005) 1965-1970
18. Pankuweit S., Moll R., Baandrup U., Portig I., Hufnagel G., and Maisch B. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34 (2003) 497-503
19. Pankuweit S., Ruppert V., Eckhardt H., Strache D., and Maisch B. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19. J Vet Med B Infect Dis Vet Public Health 52 (2005) 344-347
20. Kühl U., Lassner D., Pauschinger M., Gross U.M., Seeberg B., Noutsias M., et al. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol 80 (2008) 1243-1251
21. Tschöpe C., Bock C.T., Kasner M., Noutsias M., Westermann D., Schwimmbeck P.L., et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111 (2005) 879-886
22. Yilmaz A., Mahrholdt H., Athanasiadis A., Vogelsberg H., Meinhardt G., Voehringer M., et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 94 (2008) 1456-1463
23. Kühl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111 (2005) 887-893
24. Heim A., Stille-Siegener M., Kandolf R., Kreuzer H., and Figulla H.R. Enterovirus-induced myocarditis: hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-alpha. Clin Cardiol 17 (1994) 563-565
25. Maisch B., Hufnagel G., Kölsch S., Funck R., Richter A., Rupp H., et al. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 29 (2004) 624-636
26. Lutton C.W., and Gauntt C.J. Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res 5 (1985) 137-146
27. Kühl U., Pauschinger M., Schwimmbeck P.L., Seeberg B., Lober C., Noutsias M., et al. Interferon-β treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107 (2003) 2793-2798
28. Schultheiss H.P., Piper C., Sowade O., Karason K., Kapp J.F., Wegscheider K., et al. The Effect of subcutaneous treatment with interferon-Beta-1b over 24 weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy. [abstract]. Circulation 118 (2008) 2312
29. Zimmermann O., Kochs M., Zwaka T.P., Kaya Z., Lepper P.M., Bienek-Ziolkowski M., et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol 104 (2005) 92-100
30. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation 99 (1999) 1091-1100
31. Gutberlet M., Spors B., Thoma T., Bertram H., Denecke T., Felix R., Noutsias M., Schultheiss H.P., and Kühl U. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 246 (2008) 401-409
32. Kindermann I., Kindermann M., Kandolf R., Klingel K., Bültmann B., Müller T., et al. Predictors of outcome in patients with suspected myocarditis. Circulation 118 (2008) 639-648
33. Schenk T., Enders M., Pollak S., Hahn R., and Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilated cardiomyopathy. J Clin Microbiol 12 (2008) [Epub ahead of print]
34. Kuethe F., Sigusch H.H., Hilbig K., Tresselt C., Glück B., Egerer R., et al. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy. Am Heart J 153 (2007) 850-858
35. Schultheiss H.P., and Kühl U. Entzündliche Herzerkrankungen. In: Classen D., Kochsiek L., Böhm M., and Schmiegel I. (Eds). Lehrbuch Innere Medizin. 6th ed (2007), Urban & Fischer, München, Germany
36. Staudt A., and Felix S.B. Immunomodulatory and immunoadsorptive treatments. Heart Fail Clin 1 (2005) 457-465
37. Vallbracht K.B., Schwimmbeck P.L., Kühl U., Seeberg B., and Schultheiss H.P. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation 110 (2004) 2938-2945
38. Bültmann B.D., Klingel K., Sotlar K., Bock C.T., Baba H.A., Sauter M., et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34 (2003) 92-95
39. Mahrholdt H., Wagner A., Deluigi C.C., Kispert E., Hager S., Meinhardt G., et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114 (2006) 1581-1590